Rescue: filter minor particles through a sterile 0.2 micron filter
Improves Skin Complexion Helps lighten skin, reduce dullness, and enhance overall skin health
The Upcoming PCAC Meeting The FDA notice confirms that the PCAC will convene this summer to evaluate whether to recommend the following seven bulk drug substances for inclusion on the 503A bulks list: July 23, 2026: BPC-157 (free base / acetate) KPV (free base / acetate) Thymosin Beta-4, Fragment (LKKTETQ) (TB-500) (free base / acetate) MOTs-C (free base / acetate) July 24, 2026: Emideltide (DSIP) (free base / acetate) Semax (free base / acetate) Epitalon (free base / acetate) All seven substances are of considerable interest to compounding pharmacies, prescribers, and patients
Research doses in preclinical models vary, commonly around 10 mg components per vial in the blend
Information We May Collect Identifiers and contact information: name, email address, telephone number, billing and shipping address, organization, and account identifiers